Last reviewed · How we verify
K1-70 intramuscular or K1-70 intravenous — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
K1-70 intramuscular or K1-70 intravenous (K1-70 intramuscular or K1-70 intravenous) — AV7 Limited.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| K1-70 intramuscular or K1-70 intravenous TARGET | K1-70 intramuscular or K1-70 intravenous | AV7 Limited | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- K1-70 intramuscular or K1-70 intravenous CI watch — RSS
- K1-70 intramuscular or K1-70 intravenous CI watch — Atom
- K1-70 intramuscular or K1-70 intravenous CI watch — JSON
- K1-70 intramuscular or K1-70 intravenous alone — RSS
Cite this brief
Drug Landscape (2026). K1-70 intramuscular or K1-70 intravenous — Competitive Intelligence Brief. https://druglandscape.com/ci/k1-70-intramuscular-or-k1-70-intravenous. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab